North America Intraoperative Neuromonitoring Market Forecast 2017-2025
KEY FINDINGS The intraoperative neuromonitoring market in North America region is expected to evolve from $1.60 billion in 2016 to $2.89 billion by 2025. The market is expected to develop at 6.83% of CAGR throughout the years 2017-2025. For the study of the market, 2016 was considered as the base year and the forecast period is from 2017 to 2025. The IONM market is growing rapidly in North America region, owing to the rising popularity amid surgeons due to the significant advantages of IONM devices in complex surgeries.
MARKET INSIGHTS The market for intraoperative neuromonitoring is segmented based on source type, methodology, and application. The market based on source type is divided into insourced IONM and outsourced IONM. The methodology segment is bifurcated into EEG, EMG, and EP. The application segment comprises of Neurosurgery, Spinal Surgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Other Surgeries, and the countries mentioned in the region are the United States, and Canada. In terms of revenue, US tops the North America region. The rising number of surgeries like vascular surgery, genitourinary surgery, neurosurgery, etc. are the major factors responsible for this significant growth.
COMPETITIVE INSIGHTS The key brands mentioned in the North America intraoperative neuromonitoring market report are Medtronic, Computational Diagnostics, Bovie Medical, Cadwell, Accurate Monitoring, Clinical Neurodiagnostics, Natus Medical, Intranerve, Medsurant Monitoring, and Emotiv.